Go Pro
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free ONMD Stock Alerts

OneMedNet (ONMD) Competitors

OneMedNet logo
$0.59 -0.01 (-1.65%)
Closing price 08/24/2026 04:00 PM Eastern
Extended Trading
$0.59 0.00 (-0.02%)
As of 07:44 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

ONMD vs. LUCY, HCAT, CCLD, DH, and HIT

Should you buy OneMedNet stock or one of its competitors? OneMedNet's main competitors and comparable companies include Innovative Eyewear (LUCY), Health Catalyst (HCAT), CareCloud (CCLD), Definitive Healthcare (DH), and Health In Tech (HIT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does OneMedNet compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCY) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, valuation, institutional ownership, earnings, media sentiment, dividends, profitability and analyst recommendations.

Innovative Eyewear has a net margin of -225.26% compared to OneMedNet's net margin of -584.20%. OneMedNet's return on equity of 0.00% beat Innovative Eyewear's return on equity.

Company Net Margins Return on Equity Return on Assets
Innovative Eyewear-225.26% -88.90% -80.34%
OneMedNet -584.20%N/A -521.20%

Innovative Eyewear has a beta of 2.72, meaning that its stock price is 172% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.14, meaning that its stock price is 14% more volatile than the broader market.

OneMedNet has lower revenue, but higher earnings than Innovative Eyewear. OneMedNet is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41M2.83-$7.59M-$1.29N/A
OneMedNet$1.36M25.73-$2.80M-$0.16N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

1.0% of Innovative Eyewear shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 1.7% of Innovative Eyewear shares are held by company insiders. Comparatively, 50.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

In the previous week, Innovative Eyewear had 17 more articles in the media than OneMedNet. MarketBeat recorded 17 mentions for Innovative Eyewear and 0 mentions for OneMedNet. Innovative Eyewear's average media sentiment score of 0.00 equaled OneMedNet'saverage media sentiment score.

Company Overall Sentiment
Innovative Eyewear Neutral
OneMedNet Neutral

Summary

Innovative Eyewear beats OneMedNet on 8 of the 13 factors compared between the two stocks.

How does OneMedNet compare to Health Catalyst?

Health Catalyst (NASDAQ:HCAT) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

In the previous week, Health Catalyst's average media sentiment score of 0.59 beat OneMedNet's score of 0.00 indicating that Health Catalyst is being referred to more favorably in the media.

Company Overall Sentiment
Health Catalyst Positive
OneMedNet Neutral

Health Catalyst currently has a consensus target price of $2.82, indicating a potential upside of 77.53%. Given Health Catalyst's stronger consensus rating and higher probable upside, equities research analysts clearly believe Health Catalyst is more favorable than OneMedNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Health Catalyst
1 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.15
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Health Catalyst has a net margin of -90.61% compared to OneMedNet's net margin of -584.20%. OneMedNet's return on equity of 0.00% beat Health Catalyst's return on equity.

Company Net Margins Return on Equity Return on Assets
Health Catalyst-90.61% -1.83% -0.80%
OneMedNet -584.20%N/A -521.20%

85.0% of Health Catalyst shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 19.4% of Health Catalyst shares are held by insiders. Comparatively, 50.2% of OneMedNet shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

OneMedNet has lower revenue, but higher earnings than Health Catalyst. OneMedNet is trading at a lower price-to-earnings ratio than Health Catalyst, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Health Catalyst$311.14M0.38-$177.97M-$3.68N/A
OneMedNet$1.36M25.73-$2.80M-$0.16N/A

Health Catalyst has a beta of 1.55, indicating that its share price is 55% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.14, indicating that its share price is 14% more volatile than the broader market.

Summary

Health Catalyst beats OneMedNet on 10 of the 15 factors compared between the two stocks.

How does OneMedNet compare to CareCloud?

CareCloud (NASDAQ:CCLD) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, media sentiment, institutional ownership, valuation, risk, analyst recommendations and earnings.

In the previous week, CareCloud had 3 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for CareCloud and 0 mentions for OneMedNet. CareCloud's average media sentiment score of 0.33 beat OneMedNet's score of 0.00 indicating that CareCloud is being referred to more favorably in the media.

Company Overall Sentiment
CareCloud Neutral
OneMedNet Neutral

CareCloud has higher revenue and earnings than OneMedNet. OneMedNet is trading at a lower price-to-earnings ratio than CareCloud, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CareCloud$128.64M0.83$10.80M$0.0735.71
OneMedNet$1.36M25.73-$2.80M-$0.16N/A

CareCloud has a net margin of 6.21% compared to OneMedNet's net margin of -584.20%. CareCloud's return on equity of 27.07% beat OneMedNet's return on equity.

Company Net Margins Return on Equity Return on Assets
CareCloud6.21% 27.07% 14.56%
OneMedNet -584.20%N/A -521.20%

CareCloud has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.14, indicating that its stock price is 14% more volatile than the broader market.

10.2% of CareCloud shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 14.8% of CareCloud shares are held by company insiders. Comparatively, 50.2% of OneMedNet shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

CareCloud presently has a consensus price target of $3.25, indicating a potential upside of 30.00%. Given CareCloud's stronger consensus rating and higher possible upside, research analysts plainly believe CareCloud is more favorable than OneMedNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CareCloud
0 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.33
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Summary

CareCloud beats OneMedNet on 14 of the 16 factors compared between the two stocks.

How does OneMedNet compare to Definitive Healthcare?

Definitive Healthcare (NASDAQ:DH) and OneMedNet (NASDAQ:ONMD) are both small-cap healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, institutional ownership, risk, valuation, media sentiment, analyst recommendations, dividends and earnings.

In the previous week, Definitive Healthcare had 4 more articles in the media than OneMedNet. MarketBeat recorded 4 mentions for Definitive Healthcare and 0 mentions for OneMedNet. Definitive Healthcare's average media sentiment score of 0.26 beat OneMedNet's score of 0.00 indicating that Definitive Healthcare is being referred to more favorably in the media.

Company Overall Sentiment
Definitive Healthcare Neutral
OneMedNet Neutral

Definitive Healthcare has a beta of 1.35, indicating that its share price is 35% more volatile than the broader market. Comparatively, OneMedNet has a beta of 1.14, indicating that its share price is 14% more volatile than the broader market.

Definitive Healthcare has a net margin of -72.28% compared to OneMedNet's net margin of -584.20%. Definitive Healthcare's return on equity of 3.55% beat OneMedNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Definitive Healthcare-72.28% 3.55% 1.63%
OneMedNet -584.20%N/A -521.20%

Definitive Healthcare currently has a consensus target price of $1.47, indicating a potential upside of 104.11%. Given Definitive Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Definitive Healthcare is more favorable than OneMedNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Definitive Healthcare
3 Sell rating(s)
5 Hold rating(s)
0 Buy rating(s)
1 Strong Buy rating(s)
1.89
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

OneMedNet has lower revenue, but higher earnings than Definitive Healthcare. OneMedNet is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Definitive Healthcare$232.70M0.33-$138.93M-$1.60N/A
OneMedNet$1.36M25.73-$2.80M-$0.16N/A

98.7% of Definitive Healthcare shares are held by institutional investors. Comparatively, 1.0% of OneMedNet shares are held by institutional investors. 17.1% of Definitive Healthcare shares are held by insiders. Comparatively, 50.2% of OneMedNet shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

Definitive Healthcare beats OneMedNet on 12 of the 16 factors compared between the two stocks.

How does OneMedNet compare to Health In Tech?

OneMedNet (NASDAQ:ONMD) and Health In Tech (NASDAQ:HIT) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, profitability, earnings, analyst recommendations, risk, institutional ownership and media sentiment.

In the previous week, Health In Tech had 3 more articles in the media than OneMedNet. MarketBeat recorded 3 mentions for Health In Tech and 0 mentions for OneMedNet. Health In Tech's average media sentiment score of 0.92 beat OneMedNet's score of 0.00 indicating that Health In Tech is being referred to more favorably in the news media.

Company Overall Sentiment
OneMedNet Neutral
Health In Tech Positive

Health In Tech has a consensus target price of $3.50, suggesting a potential upside of 260.82%. Given Health In Tech's stronger consensus rating and higher possible upside, analysts plainly believe Health In Tech is more favorable than OneMedNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
OneMedNet
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Health In Tech
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

OneMedNet has a beta of 1.14, meaning that its stock price is 14% more volatile than the broader market. Comparatively, Health In Tech has a beta of 2.82, meaning that its stock price is 182% more volatile than the broader market.

Health In Tech has a net margin of 0.00% compared to OneMedNet's net margin of -584.20%.

Company Net Margins Return on Equity Return on Assets
OneMedNet-584.20% N/A -521.20%
Health In Tech N/A N/A N/A

1.0% of OneMedNet shares are held by institutional investors. 50.2% of OneMedNet shares are held by company insiders. Comparatively, 77.7% of Health In Tech shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

OneMedNet has higher earnings, but lower revenue than Health In Tech. Health In Tech is trading at a lower price-to-earnings ratio than OneMedNet, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
OneMedNet$1.36M25.73-$2.80M-$0.16N/A
Health In Tech$32.83M1.94-$4.59M-$0.07N/A

Summary

Health In Tech beats OneMedNet on 12 of the 16 factors compared between the two stocks.

Get OneMedNet News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ONMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONMD vs. The Competition

Export
MetricOneMedNetHealthcare Technology IndustryHealthcare SectorNASDAQ Exchange
Market Cap$35.57M$1.72B$7.36B$12.81B
Dividend YieldN/A4.69%2.54%10.79%
P/E Ratio-3.6921.28270.5924.05
Price / Sales25.7379.57646.86105.00
Price / CashN/A31.6929.0336.89
Price / Book-9.845.8211.176.40
Net Income-$2.80M-$18.66M$3.46B$347.95M
7 Day Performance-1.73%1.02%1.74%1.48%
1 Month Performance-4.03%12.71%7.34%5.13%
1 Year Performance-22.73%-16.23%26.14%17.00%

OneMedNet Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONMD
OneMedNet
0.642 of 5 stars		$0.59
-1.7%		N/A-24.4%$35.57M$1.36MN/A2
LUCY
Innovative Eyewear
0.7551 of 5 stars		$0.70
-2.3%		N/A-43.7%$4.44M$2.98MN/A9
HCAT
Health Catalyst
3.1539 of 5 stars		$1.78
+3.8%		$2.93
+65.2%		-51.5%$133.59M$311.14MN/A1,200
CCLD
CareCloud
3.8389 of 5 stars		$2.61
+0.9%		$3.25
+24.3%		-11.7%$110.82M$128.64M37.263,650
DH
Definitive Healthcare
2.5065 of 5 stars		$0.70
+5.3%		$1.47
+111.7%		-82.2%$74.30M$241.52MN/A970

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:ONMD) was last updated on 8/25/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel